Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Psychemedics Corporation

Market Cap 9.79M 8.54M 7.87M 7.42M 13.84M 924M 13.95M 93.63M 36.35M 454M 36.75M 35.96M 1.58B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.32M 7.67M 7.22M 13.48M 900M 13.6M 91.23M 35.42M 443M 35.81M 35.04M 1.54B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
Current month-8.33%
1 month-8.33%
3 months+57.14%
6 months+22.22%
Current year+37.50%
1 month 2.2
Extreme 2.2
2.2
Current year 1.33
Extreme 1.33
2.5
1 year 1.33
Extreme 1.33
2.5
3 years 1.11
Extreme 1.11
5.15
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap.
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-2.22%-52.48% 13.46M
+2.19%+6.89%+38.11%+360.52% 32.43B
-0.20%-2.17%-25.27%-43.43% 6.94B
+1.74%-7.60%-4.99%+71.26% 4.15B
+0.67%+6.00%+13.58%+64.12% 2.93B
+4.59%+8.63%-7.85%+779.43% 1.67B
+0.39%+9.62%+23.91%-31.35% 1.64B
+0.37%+1.82%-12.58%-67.19% 1.68B
-2.50%-2.18%+10.10%-4.81% 1.58B
+4.09%+25.35% - - 1.47B
Average +1.13%-1.54%+3.64%+119.56% 5.45B
Weighted average by Cap. +1.65%+1.66%+20.75%+245.21%

Financials

2023 2024
Net sales 22.1M 19.28M 17.77M 16.74M 31.23M 2.08B 31.5M 211M 82.05M 1.03B 82.94M 81.16M 3.56B 19.68M 17.17M 15.83M 14.91M 27.82M 1.86B 28.06M 188M 73.09M 914M 73.88M 72.3M 3.17B
Net income -4.15M -3.62M -3.34M -3.15M -5.87M -392M -5.92M -39.72M -15.42M -193M -15.59M -15.26M -670M -1.86M -1.62M -1.5M -1.41M -2.63M -176M -2.65M -17.8M -6.91M -86.37M -6.98M -6.83M -300M
Net Debt 334K 291K 269K 253K 472K 31.5M 476K 3.19M 1.24M 15.5M 1.25M 1.23M 53.86M -251K -219K -202K -190K -355K -23.68M -358K -2.4M -932K -11.65M -942K -922K -40.47M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!